The function and regulation of the C. elegans Haspin histone kinase homolog, HASP-1
线虫 Haspin 组蛋白激酶同源物 HASP-1 的功能和调节
基本信息
- 批准号:10792737
- 负责人:
- 金额:$ 40.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-22 至 2026-09-20
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimalsBindingBiologicalCRISPR/Cas technologyCaenorhabditis elegansCancer ModelCancer cell lineCell Culture TechniquesCell CycleCell divisionCellsChromosome SegregationChromosomesClinicalClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsComplexConflict (Psychology)Congenital AbnormalityDefectDown SyndromeDrug TargetingEnsureFailureGenesGeneticGenomeGoalsHandHaspinHealthHermaphroditismHistone H3Homologous GeneHumanInfertilityInheritedInstitutionInvestigationLiteratureMalignant NeoplasmsMeiosisMitosisMitotic CheckpointMolecularMolecular ConformationMonitorMorphologyMusMutationNormal CellOocytesOrganismPathway interactionsPharmaceutical PreparationsPhosphorylationPhosphotransferasesPlayPostbaccalaureateProcessProtamine KinaseProtein KinaseProteinsRecurrenceRegulationReportingResearchResearch PersonnelRoleSignal TransductionSomatic CellSpecific qualifier valueSpermatocytesSpermatogenesisSystemTestingTherapeuticTimeTissuesToxic effectTrainingWorkXenograft Modelanticancer activitybiomedical scientistcancer cellcell typechemotherapychromosome missegregationcohesiondrug developmentexperimental studygermline stem cellsin vivoinhibitorinhibitor therapyinsightknock-downmodel organismnext generationpreventprogramsprotein complexrecruitrefractory cancersegregationside effectsperm celltargeted treatmenttissue/cell culturetoolundergraduate student
项目摘要
Project Summary/Abstract
The process of passing on chromosomes when cells divide must be carefully monitored because errors
cause birth defects and infertility and are a hallmark of cancer. Cells use a variety of mechanisms to monitor
the process of chromosome segregation and these mechanisms are often the target of drugs being developed
in the hopes of finding chemotherapeutics that will kill cancer cells while having low toxicity to normal cells. The
Chromosomal Passenger Complex (CPC) is a protein complex that monitors chromosome segregation. To
provide its essential functions, the CPC must be recruited onto chromosomes at the right place and time. The
mechanisms that target the CPC to chromosomes are not fully understood, but two key pathways have been
discovered that rely on the activity of the protein kinases Haspin and Bub1. While the kinase Bub1 has been
well studied since its discovery as part of the mitotic checkpoint signal, Haspin is a newly discovered kinase
and fundamental questions abouts its function and regulation have not yet been answered. Better
understanding Haspin’s function is critical because chemotherapy drugs targeting Haspin have shown promise.
Haspin has features that make its inhibitors less likely to produce side effects, and multiple inhibitors have
recently shown efficacy against a variety of cancer models and low toxicity to normal cells.
Investigations into Haspin’s function have so far been limited to a small number of cell types undergoing
mitosis in cell culture, which offers only a partial understanding of this molecule’s function. This proposal
develops a new system to study Haspin function in a variety of cell types in vivo using the model organism C.
elegans, which features powerful genetic and cell biological tools. Conditional knockdown of the C. elegans
Haspin protein, HASP-1, combined with specific mutations in HASP-1 and associated proteins using CRISPR
gene editing, will enable us to accomplish the following Specific Aims: 1) Determine the relative contribution of
the Haspin and Bub1 pathways to CPC recruitment in different cell types in C. elegans, 2) Identify the
mechanism by which HASP-1 is recruited to chromosomes, and 3) Determine the mechanisms by which
HASP-1 becomes activated during mitosis and meiosis. Our experimental system allows us to address these
Specific Aims in multiple cell types and in meiosis, a specialized cell division where these types of mechanistic
studies are typically not possible in other animal systems. The proposed work will provide new insights into the
molecular mechanisms underlying the function of this important cell cycle regulator, which will positively impact
human health, especially as Haspin inhibitors show up more in clinical use. Proposed experiments will be
performed in close collaboration with undergraduate researchers and a post-baccalaureate researcher,
enhancing the research capacity of our institution and training the next generation of biomedical scientists.
项目摘要/摘要
当必须仔细监测细胞分裂时,传递染色体的过程是因为错误
导致先天缺陷和不育,是癌症的标志。细胞使用多种机制来监测
染色体分离和这些机制的过程通常是正在开发的药物的目标
希望找到化学治疗剂,可以杀死癌细胞,而对正常细胞的毒性低。
染色体乘客复合物(CPC)是一种监视染色体分离的蛋白质复合物。到
提供其基本功能,必须将CPC招募到正确的位置和时间的染色体上。这
将CPC靶向染色体的机制尚不完全了解,但是已经有两个关键途径
发现依赖于蛋白激酶haspin和bub1的活性。激酶Bub1是
自从发现作为有丝分裂检查点信号的一部分以来,Haspin是一种新发现的激酶
尚未回答有关其功能和法规的基本问题。更好的
了解Haspin的功能至关重要,因为靶向Haspin的化学疗法药物已经表现出了希望。
Haspin具有使其抑制剂产生副作用的可能性较小的功能,并且多种抑制剂具有
最近显示出针对多种癌症模型的效率和对正常细胞的低毒性。
到目前为止,对Haspin功能的调查仅限于正在进行的少数细胞类型
细胞培养中的有丝分裂仅提供对该分子功能的部分理解。这个建议
使用模型有机体C开发了一个新的系统,用于研究体内各种细胞类型的HASPIN功能。
秀丽隐杆线,具有强大的遗传和细胞生物学工具。秀丽隐杆线虫的有条件击倒
HASPIN蛋白HASP-1与HASP-1和相关蛋白的特异性突变结合使用CRISPR
基因编辑,将使我们能够完成以下特定目标:1)确定
秀丽隐杆线虫中不同细胞类型中CPC募集的Haspin和Bub1途径,2)确定
将HASP-1募集到染色体的机制,以及3)确定的机制
HASP-1在有丝分裂和减数分裂过程中被激活。我们的实验系统使我们能够解决这些问题
在多种细胞类型和减数分裂中的特定目的是专门的细胞分裂
在其他动物系统中,通常无法进行研究。拟议的工作将为您提供新的见解
该重要细胞周期调节剂功能的基础的分子机制,这将积极影响
人类健康,尤其是Haspin抑制剂在临床使用方面的表现更多。建议的实验将是
与本科研究人员和学士后的研究人员密切合作,
增强我们机构的研究能力,并培训下一代生物医学科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J Wynne其他文献
Vibrio vulnificus iron transport mutant has normal pathogenicity in C. elegans
创伤弧菌铁转运突变体对秀丽隐杆线虫具有正常致病性
- DOI:
10.17912/micropub.biology.000124 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Adria K. Bowles;David J Wynne;Ryan J Kenton - 通讯作者:
Ryan J Kenton
Correction: ZHP-3 Acts at Crossovers to Couple Meiotic Recombination with Synaptonemal Complex Disassembly and Bivalent Formation in C. elegans
更正:ZHP-3 在交叉中发挥作用,将减数分裂重组与联会复合体分解和秀丽隐杆线虫中的二价形成结合起来
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:4.5
- 作者:
N. Bhalla;David J Wynne;V. Jantsch;A. Dernburg - 通讯作者:
A. Dernburg
David J Wynne的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J Wynne', 18)}}的其他基金
Determining how the spindle assembly checkpoint monitors chromosome biorientation
确定纺锤体装配检查点如何监控染色体生物取向
- 批准号:
8397884 - 财政年份:2012
- 资助金额:
$ 40.85万 - 项目类别:
Determining how the spindle assembly checkpoint monitors chromosome biorientation
确定纺锤体装配检查点如何监控染色体生物取向
- 批准号:
8523035 - 财政年份:2012
- 资助金额:
$ 40.85万 - 项目类别:
相似国自然基金
熏蒸结合动物堆肥对土壤-蔬菜系统抗生素抗性基因的影响机制
- 批准号:42307033
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:82201339
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
一种新型PRC1变体在不同细胞类型中的结合动态与功能研究
- 批准号:31900422
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
多配体协同作用对铬在动物皮内的渗透-结合性能和交联强度的调控机制及应用
- 批准号:21908149
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
- 批准号:
10677394 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别:
Illumination of TAAR2 Location, Function and Regulators
TAAR2 位置、功能和调节器的阐明
- 批准号:
10666759 - 财政年份:2023
- 资助金额:
$ 40.85万 - 项目类别: